Unlocking the potential of zolbetuximab in CLDN18.2-positive gastric cancer: A comprehensive systematic review of clinical efficacy and safety
Department
Medicine
Document Type
Conference Proceeding
Publication Title
Journal of Clinical Oncology
Conference Name
American Society of Clinical Oncology (ASCO) Annual Meeting
Conference Date
2025-05-30 - 2025-06-03
First Page
e16069
DOI
10.1200/JCO.2025.43.16_suppl.e16069
Volume
43
Issue
16_suppl
Publication Date
6-1-2025
Recommended Citation
Gul, O., Ashfaque, A., Waheed, A., Rasheed, S., Maryam, B., Afshan, R., & Gul, M. H. (2025). Unlocking the potential of zolbetuximab in CLDN18.2-positive gastric cancer: A comprehensive systematic review of clinical efficacy and safety. Journal of Clinical Oncology, 43 (16_suppl), e16069. https://doi.org/10.1200/JCO.2025.43.16_suppl.e16069
COinS